James Engelhart

Insider Reports History

Entity
Individual
Location
C/O Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven, Connecticut
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Engelhart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Strategic Advisor Stock Options (Right to buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by James Engelhart

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 15 -$2.36M 4 Oct 3, 2022 Strategic Advisor
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 8 -$355K 4 Jan 7, 2022 Strategic Advisor
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 10, 2021 5 -$3.59M 4 Dec 10, 2021 Chief Financial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$198K 4 Nov 26, 2021 Chief Financial Officer